Complement C4d-specific antibodies for the diagnosis of lung cancer

Development of molecular markers that help to identify high-risk individuals or diagnose indeterminate pulmonary nodules could have a major impact on lung cancer clinical management. In this study, we evaluated the diagnostic potential of a newly-developed ELISA that specifically detects complement...

Descripción completa

Detalles Bibliográficos
Autores principales: Ajona, Daniel, Okrój, Marcin, Pajares, María J., Agorreta, Jackeline, Lozano, María D., Zulueta, Javier J., Verri, Carla, Roz, Luca, Sozzi, Gabriella, Pastorino, Ugo, Massion, Pierre P., Montuenga, Luis M., Blom, Anna M., Pio, Ruben
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5814217/
https://www.ncbi.nlm.nih.gov/pubmed/29464077
http://dx.doi.org/10.18632/oncotarget.23690

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5814217/
https://www.ncbi.nlm.nih.gov/pubmed/29464077
http://dx.doi.org/10.18632/oncotarget.23690

Ejemplares similares